We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
-5%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$1.45B
AUM Growth
+$12.9M
(+0.9%)
Cap. Flow
+$99.9M
Cap. Flow
% of AUM
6.88%
Top 10 Holdings %
Top 10 Hldgs %
34.13%
Holding
1,140
New
132
Increased
492
Reduced
188
Closed
50
Avg Time Held
2.9
years
Top 10 Avg Time Held
2.5
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$23.9M |
| 2 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$18.8M |
| 3 |
State Street SPDR S&P Dividend ETF
SDY
|
+$14.2M |
| 4 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$13.4M |
| 5 |
Apple
AAPL
|
+$6.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$24.4M |
| 2 |
iShares Gold Trust
IAU
|
+$8.75M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.91M |
| 4 |
Ally Financial
ALLY
|
+$4.53M |
| 5 |
Newmont
NEM
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.9% |
| 2 | Technology | 6.89% |
| 3 | Healthcare | 4.85% |
| 4 | Financials | 4% |
| 5 | Industrials | 3.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
876
Virtus Real Asset Income ETF
VRAI
$18.3M
| $6K | ﹤0.01% |
268
| – | – |
2022 Q2
1 quarter
|
|
|
ASLN
877
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $6K | ﹤0.01% |
+268
| New | +$6.91K |
2022 Q3
0 quarters
|
|
878
DELISTED
Ansys
ANSS
| $5K | ﹤0.01% |
22
-1,339
| -98% | -$342K |
2018 Q4
15 quarters
|
|
879
ARK Blockchain & Fintech Innovation ETF
ARKF
$878M
| $5K | ﹤0.01% |
340
| – | – |
2021 Q1
6 quarters
|
|
880
Blink Charging
BLNK
$61.4M
| $5K | ﹤0.01% |
+300
| New | +$6.16K |
2022 Q3
0 quarters
|
|
881
FT Vest US Equity Deep Buffer ETF October
DOCT
$403M
| $5K | ﹤0.01% |
152
| – | – |
2021 Q4
3 quarters
|
|
882
Eaton Vance Municipal Bond Fund
EIM
$455M
| $5K | ﹤0.01% |
+533
| New | +$5.68K |
2022 Q3
0 quarters
|
|
883
Foghorn Therapeutics
FHTX
$110M
| $5K | ﹤0.01% |
605
| – | – |
2021 Q1
6 quarters
|
|
884
Strategy Shares Nasdaq 7HANDL Index ETF
HNDL
$626M
| $5K | ﹤0.01% |
259
| – | – |
2022 Q2
1 quarter
|
|
885
H&R Block
HRB
$5.96B
| $5K | ﹤0.01% |
+106
| New | +$4.49K |
2022 Q3
0 quarters
|
|
886
Humana
HUM
$49.6B
| $5K | ﹤0.01% |
+10
| New | +$4.86K |
2022 Q3
0 quarters
|
|
887
Cheniere Energy
LNG
$59.8B
| $5K | ﹤0.01% |
+30
| New | +$4.55K |
2022 Q3
0 quarters
|
|
888
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.9B
| $5K | ﹤0.01% |
+60
| New | +$5.89K |
2022 Q3
0 quarters
|
|
889
NXP Semiconductors
NXPI
$57.8B
| $5K | ﹤0.01% |
39
+22
| +129% | +$3.69K |
2021 Q1
6 quarters
|
|
890
Piedmont Realty Trust
PDM
$1.14B
| $5K | ﹤0.01% |
509
| – | – |
2019 Q1
14 quarters
|
|
891
Prudential Financial
PRU
$40B
| $5K | ﹤0.01% |
60
| – | – |
2022 Q1
2 quarters
|
|
892
Royal Caribbean
RCL
$74.3B
| $5K | ﹤0.01% |
129
+29
| +29% | +$1.18K |
2022 Q2
1 quarter
|
|
893
Virgin Galactic
SPCE
$368M
| $5K | ﹤0.01% |
50
| – | – |
2020 Q3
8 quarters
|
|
894
Urban Edge Properties
UE
$2.46B
| $5K | ﹤0.01% |
+395
| New | +$6.16K |
2022 Q3
0 quarters
|
|
895
Vanguard Consumer Staples ETF
VDC
$8.01B
| $5K | ﹤0.01% |
28
| – | – |
2021 Q2
5 quarters
|
|
896
Vir Biotechnology
VIR
$1.69B
| $5K | ﹤0.01% |
245
+50
| +26% | +$1.27K |
2022 Q2
1 quarter
|
|
897
DELISTED
Desktop Metal, Inc.
DM
| $5K | ﹤0.01% |
+200
| New | +$5.6K |
2022 Q3
0 quarters
|
|
898
DELISTED
Marathon Oil Corporation
MRO
| $5K | ﹤0.01% |
202
+2
| +1% | +$47 |
2020 Q3
8 quarters
|
|
|
TCDA
899
DELISTED
Tricida, Inc. Common Stock
TCDA
| $5K | ﹤0.01% |
500
| – | – |
2020 Q1
10 quarters
|
|
|
TWTR
900
DELISTED
Twitter, Inc.
TWTR
| $5K | ﹤0.01% |
125
| – | – |
2021 Q1
6 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q3 2022 Portfolio in Review
As of Q3 2022, Capital Analysts LLC held 1,140 positions worth $1.45B, up 0.9% from $1.44B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Capital Analysts LLC deployed $99.9M of net new capital in Q3 2022, opening 132 new positions and adding to 492 existing holdings. Its largest new stake was Fidelity MSCI Health Care Index ETF: 64,153 shares worth $3.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, up from 69% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $24.4M trimmed.
- Capital Analysts LLC's largest Q3 2022 buy was Fidelity MSCI Health Care Index ETF: 64,153 shares worth $3.7M.
- Capital Analysts LLC added most to JPMorgan Ultra-Short Income ETF in Q3 2022, an estimated $23.9M increase.
- Capital Analysts LLC's biggest Q3 2022 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $24.4M.
- Capital Analysts LLC fully exited Ally Financial in Q3 2022, selling an estimated $4.53M.
- Capital Analysts LLC's ten largest holdings make up 34% of its $1.45B portfolio in Q3 2022.
- Capital Analysts LLC opened 132 new positions and closed 50 in Q3 2022.
- Capital Analysts LLC's portfolio value rose 0.9% quarter-over-quarter to $1.45B.
Based on Capital Analysts LLC's 13F filing for Q3 2022, filed 14 Nov 2022.